In Figure 3A, aberrant p16 hypermethylation is not remarkably higher in advanced MM (III) than that in early staged MM (I &II), OR=1.07, 95% CI=0.65-1.74, p=0.80. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.